glp-1 drugs and breast cancer Study links to lower diagnosis rates Glucagon-like peptide 1 receptor agonists
Description
doi: 10.1111/dom.14710
Bergmann NC, Gasbjerg LS, Heimbrger SM, Krogh LSL, Dela F, Hartmann B, et al
DPP-4 inhibitors are capable of lowering HbA1c percentage by ~0.51 unit
doi: 10.1016/j.molmet.2020.101090 10 IqbalJWuHHuNZhouYLiLXiaoFet al
Ozempics Focus on GLP-1: Ozempic, on the other hand, works specifically as a GLP-1 receptor agonist
Clinical significance of nonalbuminuric renal impairment in type 2 diabetes
